Skip to main content

Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

Objective

INPACT aims at the pre-clinical development of innovative drugs and drug formulations against selected cancers (eg prostate cancer) and pathogenic bacteria (eg S. aureus). The INPACT consortium allies the expertise of both academic and industrial R&D partners that contribute with their own unique technologies to achieve new drugs that are only possible to develop in an integrative effort. Academic partners have unique knowledge and technologies on supercharged viral proteins-derived cell-penetrating peptides (eg from Dengue virus) and ultra-resistant cyclic peptides that may be transferred to the industrial partners, which in turn have specialized proprietary technologies on anticancer and/or peptide drugs’ technologies. The judicious exchange of knowledge among partners will lead to new resistant peptides for trans-barrier delivery of drugs (eg cyclic peptide-drug chimeras) and bacterial killing (both planktonic and biofilms). INPACT includes four leading academic partners (from Portugal, Spain, Australia, and Brazil) and three consolidated biotech SMEs (one from Portugal and two Spain).
In addition to the R&D project itself, INPACT involves at the highest possible level a top business school in Europe (IESE, Barcelona, Spain), a consolidated media partner specialised in science communication (Ciencia Hoje, Rio de Janeiro, Brazil) and experts in international science funding from one of the top US universities (University of Stanford). The consortium will be the perfect environment for young researchers to acquire knowledge and skills in science, technology, entrepreneurship, business, and communication so they can pro-actively tailor their career path in a life-long learning perspective. This is a contribution towards the advancement of Europe through the use of research and education for societal development and economic growth.

Coordinator

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Net EU contribution
€ 463 500,00
Address
Avenida Prof Egas Moniz
1649 028 Lisboa
Portugal

See on map

Region
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Activity type
Research Organisations
Non-EU contribution
€ 238 500,00

Participants (5)

UNIVERSIDAD POMPEU FABRA
Spain
Net EU contribution
€ 180 000,00
Address
Placa De La Merce, 10-12
08002 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 135 000,00
UNIVERSIDAD DE NAVARRA
Spain
Net EU contribution
€ 49 500,00
Address
Campus Universitario Edificio Central
31080 Pamplona

See on map

Region
Noreste Comunidad Foral de Navarra Navarra
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 72 000,00
TECHNOPHAGE INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA SA
Portugal
Net EU contribution
€ 40 500,00
Address
Avenida Professor Egas Moniz Edificio Egas Moniz Piso 2 Sala A 8
1649 028 Lisboa

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 9 000,00
CENTRO ATLANTICO DEL MEDICAMENTO, SA
Spain
Net EU contribution
€ 45 000,00
Address
Avda Trinidad 61 La S/n Planta 7 Aulario Torre Prof Agustin Arevalo
38204 San Cristobal De La Laguna Tenerife

See on map

Region
Canarias Canarias Tenerife
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 9 000,00
PROTEODESIGN SL
Spain
Net EU contribution
€ 72 000,00
Address
Baldiri Reixac 10-12
08028 Barcelona

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 76 500,00

Partners (4)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
United States
Net EU contribution
€ 0,00
Address
Serra Mall 450
94305 2004 Stanford

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

UNIVERSIDADE FEDERAL DO RIO DE JANEIRO
Brazil
Net EU contribution
€ 0,00
Address
Av Brigadeiro Trompowski Sn 2
21941 590 Rio De Janeiro

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 211 500,00
Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

THE UNIVERSITY OF QUEENSLAND
Australia
Net EU contribution
€ 0,00
Non-EU contribution
€ 166 500,00
Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

INSTITUTO CIENCIA HOJE-ICH
Brazil
Net EU contribution
€ 0,00
Address
Av Venceslau Bras 71 Casa 27 E Pavi Lhao Ma Botafogo
22290 140 Rio De Janeiro

See on map

Activity type
Other
Non-EU contribution
€ 108 000,00